Eiger BioPharmaceuticals
14 clinical trials · Sponsor
◉ Watch Eiger BioPharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV (NCT05070364) | Eiger BioPharmaceuticals | 2021-12-21 |
| Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a (NCT03719313) | Eiger BioPharmaceuticals | 2018-12-01 |
| Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia (NCT03373435) | Eiger BioPharmaceuticals | 2018-03-19 |
Track Eiger BioPharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.